within Pharmacolibrary.Drugs.ATC.C;

model C07AG02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 55 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,
    adminCount     = 1,
    Vd             = 0.115,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 1200
  );

  annotation(Documentation(
    info ="<html><body><p>Carvedilol is a non-selective beta-adrenergic blocker with alpha-1 blocking activity, primarily used for the treatment of heart failure, hypertension, and left ventricular dysfunction after myocardial infarction. It is an approved and widely used cardiovascular agent.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose administration.</p><h4>References</h4><ol><li><p>Kim, MS, &amp; Baek, IH (2018). Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 111 13–19. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2017.09.029&quot;>10.1016/j.ejps.2017.09.029</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28942006/&quot;>https://pubmed.ncbi.nlm.nih.gov/28942006</a></p></li><li><p>Lim, TH, et al., &amp; Choi, DH (2015). Effects of cilostazol on the pharmacokinetics of carvedilol after oral and intravenous administration in rats. <i>Journal of physiology and pharmacology : an official journal of the Polish Physiological Society</i> 66(4) 591–597. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26348083/&quot;>https://pubmed.ncbi.nlm.nih.gov/26348083</a></p></li><li><p>Yamamoto, PA, et al., &amp; de Moraes, NV (2023). Effect of Roux-En-Y Gastric Bypass in the Pharmacokinetics of (R)-Carvedilol and (S)-Carvedilol. <i>Journal of clinical pharmacology</i> 63(7) 838–847. DOI:<a href=&quot;https://doi.org/10.1002/jcph.2221&quot;>10.1002/jcph.2221</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36854819/&quot;>https://pubmed.ncbi.nlm.nih.gov/36854819</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07AG02;
